Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
Goubet AG, Lordello L, Alves Costa Silva C, Peguillet I, Gazzano M, Mbogning-Fonkou MD, Thelemaque C, Lebacle C, Thibault C, Audenet F, Pignot G, Gravis G, Helissey C, Campedel L, Roupret M, Xylinas E, Ouzaid I, Dubuisson A, Mazzenga M, Flament C, Ly P, Marty V, Signolle N, Sauvat A, Sbarrato T, Filahi M, Davin C, Haddad G, Bou Khalil J, Bleriot C, Danlos FX, Dunsmore G, Mulder K, Silvin A, Raoult T, Archambaud B, Belhechmi S, Gomperts Boneca I, Cayet N, Moya-Nilges M, Mallet A, Daillere R, Rouleau E, Radulescu C, Allory Y, Fieschi J, Rouanne M, Ginhoux F, Le Teuff G, Derosa L, Marabelle A, Van Dorp J, Van Dijk N, Van Der Heijden MS, Besse B, Andre F, Merad M, Kroemer G, Scoazec JY, Zitvogel L, Loriot Y. Goubet AG, et al. Among authors: fieschi j. Cancer Discov. 2022 Oct 5;12(10):2280-2307. doi: 10.1158/2159-8290.CD-22-0201. Cancer Discov. 2022. PMID: 35929803
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer.
Marliot F, Chen X, Kirilovsky A, Sbarrato T, El Sissy C, Batista L, Van den Eynde M, Haicheur-Adjouri N, Anitei MG, Musina AM, Scripcariu V, Lagorce-Pagès C, Hermitte F, Galon J, Fieschi J, Pagès F. Marliot F, et al. Among authors: fieschi j. J Immunother Cancer. 2020 May;8(1):e000272. doi: 10.1136/jitc-2019-000272. J Immunother Cancer. 2020. PMID: 32448799 Free PMC article.
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy.
Daillère R, Derosa L, Bonvalet M, Segata N, Routy B, Gariboldi M, Budinská E, De Vries IJM, Naccarati AG, Zitvogel V, Caldas C, Engstrand L, Loilbl S, Fieschi J, Heinzerling L, Kroemer G, Zitvogel L. Daillère R, et al. Among authors: fieschi j. Oncoimmunology. 2020 Jun 3;9(1):1774298. doi: 10.1080/2162402X.2020.1774298. Oncoimmunology. 2020. PMID: 32934879 Free PMC article. Review.
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study.
Moretto R, Rossini D, Catteau A, Antoniotti C, Giordano M, Boccaccino A, Ugolini C, Proietti A, Conca V, Kassambara A, Pietrantonio F, Salvatore L, Lonardi S, Tamberi S, Tamburini E, Poma AM, Fieschi J, Fontanini G, Masi G, Galon J, Cremolini C. Moretto R, et al. Among authors: fieschi j. J Immunother Cancer. 2023 Apr;11(4):e006633. doi: 10.1136/jitc-2022-006633. J Immunother Cancer. 2023. PMID: 37085190 Free PMC article.
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer.
Ghiringhelli F, Bibeau F, Greillier L, Fumet JD, Ilie A, Monville F, Laugé C, Catteau A, Boquet I, Majdi A, Morgand E, Oulkhouir Y, Brandone N, Adam J, Sbarrato T, Kassambara A, Fieschi J, Garcia S, Lepage AL, Tomasini P, Galon J. Ghiringhelli F, et al. Among authors: fieschi j. EBioMedicine. 2023 Jun;92:104633. doi: 10.1016/j.ebiom.2023.104633. Epub 2023 May 25. EBioMedicine. 2023. PMID: 37244159 Free PMC article.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Antoniotti C, Rossini D, Pietrantonio F, Catteau A, Salvatore L, Lonardi S, Boquet I, Tamberi S, Marmorino F, Moretto R, Ambrosini M, Tamburini E, Tortora G, Passardi A, Bergamo F, Kassambara A, Sbarrato T, Morano F, Ritorto G, Borelli B, Boccaccino A, Conca V, Giordano M, Ugolini C, Fieschi J, Papadopulos A, Massoué C, Aprile G, Antonuzzo L, Gelsomino F, Martinelli E, Pella N, Masi G, Fontanini G, Boni L, Galon J, Cremolini C; GONO Foundation Investigators. Antoniotti C, et al. Among authors: fieschi j. Lancet Oncol. 2022 Jul;23(7):876-887. doi: 10.1016/S1470-2045(22)00274-1. Epub 2022 May 27. Lancet Oncol. 2022. PMID: 35636444 Clinical Trial.
Use of parenteral lipid emulsions in French neonatal ICUs.
Lapillonne A, Fellous L, Kermorvant-Duchemin E; French neonatal departments. Lapillonne A, et al. Nutr Clin Pract. 2011 Dec;26(6):672-80. doi: 10.1177/0884533611425681. Nutr Clin Pract. 2011. PMID: 22205555
Deeply virtual compton scattering off the neutron.
Mazouz M, Camsonne A, Camacho CM, Ferdi C, Gavalian G, Kuchina E, Amarian M, Aniol KA, Beaumel M, Benaoum H, Bertin P, Brossard M, Chen JP, Chudakov E, Craver B, Cusanno F, de Jager CW, Deur A, Feuerbach R, Fieschi JM, Frullani S, Garçon M, Garibaldi F, Gayou O, Gilman R, Gomez J, Gueye P, Guichon PA, Guillon B, Hansen O, Hayes D, Higinbotham D, Holmstrom T, Hyde CE, Ibrahim H, Igarashi R, Jiang X, Jo HS, Kaufman LJ, Kelleher A, Kolarkar A, Kumbartzki G, Laveissiere G, Lerose JJ, Lindgren R, Liyanage N, Lu HJ, Margaziotis DJ, Meziani ZE, McCormick K, Michaels R, Michel B, Moffit B, Monaghan P, Nanda S, Nelyubin V, Potokar M, Qiang Y, Ransome RD, Réal JS, Reitz B, Roblin Y, Roche J, Sabatié F, Saha A, Sirca S, Slifer K, Solvignon P, Subedi R, Sulkosky V, Ulmer PE, Voutier E, Wang K, Weinstein LB, Wojtsekhowski B, Zheng X, Zhu L; Jefferson Lab Hall A Collaboration. Mazouz M, et al. Among authors: fieschi jm. Phys Rev Lett. 2007 Dec 14;99(24):242501. doi: 10.1103/PhysRevLett.99.242501. Epub 2007 Dec 10. Phys Rev Lett. 2007. PMID: 18233443
Scaling tests of the cross section for deeply virtual Compton scattering.
Camacho CM, Camsonne A, Mazouz M, Ferdi C, Gavalian G, Kuchina E, Amarian M, Aniol KA, Beaumel M, Benaoum H, Bertin P, Brossard M, Chen JP, Chudakov E, Craver B, Cusanno F, de Jager CW, Deur A, Feuerbach R, Fieschi JM, Frullani S, Garçon M, Garibaldi F, Gayou O, Gilman R, Gomez J, Gueye P, Guichon PA, Guillon B, Hansen O, Hayes D, Higinbotham D, Holmstrom T, Hyde-Wright CE, Ibrahim H, Igarashi R, Jiang X, Jo HS, Kaufman LJ, Kelleher A, Kolarkar A, Kumbartzki G, Laveissière G, Lerose JJ, Lindgren R, Liyanage N, Lu HJ, Margaziotis DJ, Meziani ZE, McCormick K, Michaels R, Michel B, Moffit B, Monaghan P, Nanda S, Nelyubin V, Potokar M, Qiang Y, Ransome RD, Réal JS, Reitz B, Roblin Y, Roche J, Sabatié F, Saha A, Sirca S, Slifer K, Solvignon P, Subedi R, Sulkosky V, Ulmer PE, Voutier E, Wang K, Weinstein LB, Wojtsekhowski B, Zheng X, Zhu L; Jefferson Lab Hall A Collaboration. Camacho CM, et al. Among authors: fieschi jm. Phys Rev Lett. 2006 Dec 31;97(26):262002. doi: 10.1103/PhysRevLett.97.262002. Epub 2006 Dec 29. Phys Rev Lett. 2006. PMID: 17280421
26 results